The include American Express, Cellectis, ForeScout Technologies, Mastercard, Mueller Water, PG&E, Party City, Regeneron Pharmaceuticals and Visa.
One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for the large cap leaders in the group.
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal and Stratasys.
24/7 Wall St. screened the Merrill Lynch US 1 list for the companies that have exhibited strong price momentum and found four that look like solid picks for the fourth quarter.
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
Investors often hear when to buy a stock, but rarely when to sell. So far in August at least 10 key Sell-equivalent analyst ratings have stood out.
Stocks were indicated to open only slightly higher on Wednesday after a mixed bag of corporate earnings. What investors need to understand is that the major equity indexes remain just under all-time…
The top analyst upgrades, downgrades and other research calls from Monday include Carbonite, Coach, Credit Suisse, DaVita, Intuit, Pandora Media, ONEOK and Regeneron.
Although Monday was an incredibly positive day for the markets, Tuesday was more or less a complete reversal. Practically every sector in the S&P 500 was down with the single exception of…
Chris Lange 24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could have the biggest boom or bust at the conference.
The top analyst upgrades, downgrades and other research calls on Friday include Celgene, Continental Resources, Hess, Renewable Energy, U.S. Bancorp and Zynga.
May 4, 2017: The S&P 500 closed slightly higher on the day, up 0.06% and 1.42 points to 2,389.55. Separately the DJIA closed down 0.03% on the day at 20,951.17, down approximately…
Chris Lange A massive new Jefferies research report reminds investors that as a rule the first quarter is traditionally slower for biotechnology stocks.
The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.
